Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H

Open source

DOI: 10.1056/nejmoa020461
Published: 2002 Aug 15
Container: The New England journal of medicine
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa020461,
  title = {Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.},
  author = {Demetri GD and von Mehren M and Blanke CD and Van den Abbeele AD and Eisenberg B and Roberts PJ and Heinrich MC and Tuveson DA and Singer S and Janicek M and Fletcher JA and Silverman SG and Silberman SL and Capdeville R and Kiese B and Peng B and Dimitrijevic S and Druker BJ and Corless C and Fletcher CD and Joensuu H},
  year = {2002},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa020461},
  url = {https://doi.org/10.1056/nejmoa020461}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
AU  - Demetri GD
AU  - von Mehren M
AU  - Blanke CD
AU  - Van den Abbeele AD
AU  - Eisenberg B
AU  - Roberts PJ
AU  - Heinrich MC
AU  - Tuveson DA
AU  - Singer S
AU  - Janicek M
AU  - Fletcher JA
AU  - Silverman SG
AU  - Silberman SL
AU  - Capdeville R
AU  - Kiese B
AU  - Peng B
AU  - Dimitrijevic S
AU  - Druker BJ
AU  - Corless C
AU  - Fletcher CD
AU  - Joensuu H
PY  - 2002
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa020461
UR  - https://doi.org/10.1056/nejmoa020461
ER  -

APA

GD, D., M, V. M., CD, B., AD, V. D. A., B, E., PJ, R., MC, H., DA, T., S, S., M, J., JA, F., SG, S., SL, S., R, C., B, K., B, P., S, D., BJ, D., C, C., CD, F., & H, J. (2002). Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.. The New England journal of medicine. https://doi.org/10.1056/nejmoa020461

Source records

pubmed · retrieved 2026-11-10T07:19:19.341Z
europe-pmc · retrieved 2026-11-10T07:19:19.357Z